14,740 Followers on Owler

Illumina

Read more
Francis DeSouza's photo - President & CEO of Illumina

President & CEO

Francis DeSouza

CEO Approval Rating

67/100

Founded:

1998

Status:

PublicIndependent CompanyNASDAQILMN

ILLUMINA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Agilent is one of Illumina's top competitors. Agilent was founded in 1999, and its headquarters is in Santa Clara, California. Agilent competes in the Electrical Components & Equipment field. Agilent has 9,200 more employees than Illumina.

Illumina Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$3.2B

Illumina's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 10.3B. Over the last four quarters, Illumina's revenue has grown by 72.7%. Specifically, in Q2 2021's revenue was $1.1B; in Q1 2021, it was $953M; in Q3 2020, it was $794M; in Q2 2020, Illumina's revenue was $633M.

Illumina Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
GRAIL, Inc.

Sep 2020

Source »
$8B
GRAIL is a biotechnology company that researches and develops organ-specific screening tests for the detection of cancer.
Enancio

Jul 2020

Source »
undisclosed
Enancio develops a cloud-based analysis platform that provides genomic data compression and sequencing solutions for the life sciences industry.
BlueBee Holding B.V.

Jun 2020

Source »
undisclosed
Bluebee is a genomics analysis platform that provides diagnostic tools and components to clinicians and research labs.
Edico Genome, Inc.

May 2018

Source »
$100M
Edico Genome develops an automation platform that analyzes sequencing data for newborns, cancer patients, scientists and drug developers.
Conexio Genomics Pty., Ltd.

Jan 2016

Source »
undisclosed
Conexio develops novel genetic sequencing and mutation detection products and services.

These are all the companies that Illumina has acquired. Illumina has acquired 16 companies and its latest acquisition was GRAIL, Inc. in Sep 2020. GRAIL is a biotechnology company that researches and develops organ-specific screening tests for the detection of cancer.

Illumina Funding History

Since Illumina was founded in 1998, it has participated in 1 round of funding. In total Illumina has raised $96.0M. Illumina's funding round was on Jul 2000 for a total of $96.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Jul 2000
$96M

Since Illumina was founded in 1998, it has participated in 1 round of funding. In total Illumina has raised $96.0M. Illumina's funding round was on Jul 2000 for a total of $96.0M

Illumina Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Ginkgo Bioworks is an organism company that develops custom microbes for agriculture, cosmetics and food sectors.
$70M
May 27, 2020
Private Equity Round
-
Encoded Therapeutics is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic disorders.
$104M
Jun 25, 2019
Series C
-
Helix is a California-based biotechnology company that provides genomic research, DNA sequencing, and related solutions for the medical sector.
$200M
Feb 28, 2018
Series B
-
HLI develops a precision health intelligence platform that offers risk analysis reports on cardiac, cancer and metabolic disorders to physicians.
$220M
Apr 04, 2016
Series B
-
Twist Bioscience is a DNA synthesis platform that provides functional genomics, drug discovery, genome engineering and bio-detection solutions.
$61M
Jan 07, 2016
Series D
Oct 30, 2018

These are all the companies that Illumina has invested in. Illumina has invested 13 companies and its latest investment was Ginkgo in May 27,. Ginkgo Bioworks is an organism company that develops custom microbes for agriculture, cosmetics and food sectors.

Illumina News

Illumina Press Releases

Illumina Videos

Social Media

Illumina Headquarters

5200 Illumina Way

San Diego, California92122

1-858-202-4500

Driving Directions »

Trending Companies

Illumina Summary

ABOUT

Overview

Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. It was founded in 1998 and headquartered in San Diego, California with 3,700 employees. It develops, manufactures and m...

CEO

Illumina's President & CEO, Francis DeSouza, currently has an approval rating of 67%. Illumina's primary competitors are Agilent, Thermo Fisher & QIAGEN.

Frequently Asked Questions about Illumina

  1. When was Illumina founded?

    Illumina was founded in 1998
  2. Who is Illumina's CEO?

    Illumina's CEO is Francis DeSouza
  3. How much revenue does Illumina generate?

    Illumina generates $3.2B in revenue
  4. How much funding does Illumina have?

    Illumina has historically raised $96M in funding
  5. Where is Illumina's headquarters?

    Illumina's headquarters is in San Diego California, USA
  1. How many employees does Illumina have?

    Illumina has 7,300 employees
  2. What sector does Illumina operate in?

    Illumina is in Biotechnology
  3. Who are Illumina's competitors?

    Illumina's top competitors are Agilent, Thermo Fisher, QIAGEN
  4. Who has Illumina invested in?

    Illumina's has invested in companies such as Ginkgo, Encoded Therapeutics, Inc., Helix OpCo LLC